2 Results for "

PF-00835231

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "PF-00835231" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-137048
CAS No.: 870153-29-0
Purity:  99.31%
Target:  

SARS-CoV HIV HCV

Research Areas:  

Infection

PF-00835231 is a CoV-2 cysteine 3C-like protease (3CL pro) inhibitor, with IC50s of 0.27 nM and 4 nM for SARS CoV-2 and SARS CoV-1 3CL pro, respectively. PF-00835231 is developed for the research of anti-SARS-CoV-2/COVID-19. PF-00835231 can inhibit cell infections and also suppress infections in animal models .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-138078
CAS No.: 2468015-78-1
Purity:  99.87%
Synonyms: PF-07304814
Target:  

SARS-CoV

Research Areas:  

Infection

Lufotrelvir (PF-07304814), a phosphate proagent of PF-00835231, acts as a potent 3CLpro protease (Mpro) inhibitor with SARS-CoV-2 antiviral activity. Lufotrelvir binds and inhibits SARS-CoV-2 3CLpro activity with a Ki of 174nM. Lufotrelvir is promising single antiviral agent and also can be used for the research of combination with other antivirals that target other critical stages of the coronavirus life cycle.
loading...
    loading...